Ocular Parameters in Patients With Sleep Apnea

June 10, 2023 updated by: Georgios Labiris, Democritus University of Thrace

Ocular Parameters Assessment With a Deep Neural Network in Patients With Sleep Apnea

The aim of this study is to assess the ocular parameters of drowsiness in patients with diagnosed Obstructive Sleep Apnea Syndrome through objective methods of ocular imaging and subjective evaluation methods (questionnaire)

Study Overview

Detailed Description

This is a single-center prospective comparative observational study. One hundred patients with drowsiness that will be examined in the Sleep Clinic of Alexandroupolis University Hospital, aged between18-70 years old, with Distance Uncorrected Visual Acuity ≥ (dUVA): 5/10 will be recruited. They will be separated into two groups, one consisting of patients with diagnosed Obstructive Sleep Apnea and one without this diagnosis, according to the Epworth Sleepiness Scale - ESS, which is a valid tool for quantifying daily sleepiness. A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented to them and a questionnaire will follow to assess the level of concentration during the video (the subtitles are crucial to understanding the video's plot). The video will be displayed in a 11.6" screen with resolution of 1920x1080 pixels, at 70 cm patient-to-screen distance. The patients' eyes will be recorded during the video with a Raspberry Pi Camera Module IR-CUT v2 (5MP,1080p) with 2 IR LED lights, connected to a Raspberry Pi 3 model v1.2, operating at the original resolution of 1080×1920, at 20 cm patient-to-camera distance and an algorithm will be developed to analyze the following parameters: 1. The complete and incomplete blinks defined by the "length of palpebral fissure-to-iris diameter" ratio, 3. Length of palpebral fissure of both eyes.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Georgios Labiris, MD, PhD
  • Phone Number: 0030 2551030405
  • Email: labiris@usa.net

Study Locations

    • Evros
      • Alexandroupolis, Evros, Greece, 68100
        • Recruiting
        • Democritus University of Thrace
        • Contact:
          • Georgios Labiris, MD, PhD
          • Phone Number: 00302551030990
          • Email: labiris@usa.net

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

patients with obstructive sleep apnea and controls (not diagnosed with οbstructive sleep apnea)

Description

Inclusion Criteria:

  • patients with obstructive sleep apnea and controls, aged 18-70 years old, with distance uncorrected visual acuity (dUVA) ≥ 5/10.

Exclusion Criteria:

  • (dUVA) <5/10,
  • intraocular pressure lowering medications
  • former corneal or fundus disease
  • neurological or psychiatric conditions
  • mental disability
  • difficulty reading

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients diagnosed with Obstructive Sleep Apnea
A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented and a questionnaire will follow to assess the level of concentration during the video
Patients not diagnosed with Obstructive Sleep Apnea
A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented and a questionnaire will follow to assess the level of concentration during the video

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total number of blinks during the 10-minute video
Time Frame: 1 week
The total number of blinks during the 10-minute video. Complete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.
1 week
Total number of complete blinks during the 10-minute video
Time Frame: 1 week
The total number of complete blinks during the 10-minute video. Complete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.
1 week
Total number of incomplete blinks during the 10-minute video
Time Frame: 1 week
The total number of incomplete blinks during the 10-minute video. Incomplete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.
1 week
Number of total blinks for each minute
Time Frame: 1 week
Number of total blinks for each minute of the 10-minute video
1 week
Number of complete blinks for each minute
Time Frame: 1 week
Number of complete blinks for each minute of the 10-minute video
1 week
Number of incomplete blinks for each minute
Time Frame: 1 week
Number of incomplete blinks per minute for each minute of the 10-minute video
1 week
Total blinks per minute
Time Frame: 1 week
Total blinks per minute during the 10-minute video
1 week
Complete blinks per minute
Time Frame: 1 week
Complete blinks per minute during the 10-minute video
1 week
Incomplete blinks per minute
Time Frame: 1 week
Incomplete blinks per minute during the 10-minute video
1 week
Length of palpebral fissure of both eyes
Time Frame: 1 week
The distance between the upper eyelid margin and the lower eyelid margin (ie. the vertical dimension of the palpebral fissure) for each frame
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fixations to the area of interest
Time Frame: 1 week
Number of fixations to the area of interest (subtitles)
1 week
Fixation duration
Time Frame: 1 week
Mean fixation duration (duration of fixation per video per participant)
1 week
Reading time
Time Frame: 1 week
The absolute reading time (the sum of the duration of all fixations and saccadic movements in the area of focus starting from the first fixation)
1 week
Participant's dedication time to the area of focus
Time Frame: 1 week
The percentage of time that each participant dedicates to the area of focus depending on the time of subtitle exposure (eg. subtitle reading time/overall subtitle exposure= 2500 msec/3000 msec=83%)
1 week
Rereadings
Time Frame: 1 week
Rereadings: the number of fixations/seccadic movements to the area of focus after the first reading (indicating of subtitlte interpretation difficulty or extended subtitle exposure time).
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Georgios Labiris, MD, PhD, Democritus University of Thrace

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Estimated)

February 1, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

June 10, 2023

First Submitted That Met QC Criteria

June 10, 2023

First Posted (Actual)

June 22, 2023

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 10, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Concentration Ability Impaired

Clinical Trials on Short video and Questionnaire

Subscribe